ON DEMAND WEBINAR
Duration: 60 minutes
At Accolade, we strive to strike a balance between clinical considerations and employee welfare. Most recently, this means potentially addressing the obesity epidemic with a new class of drugs - GLP-1s.
HR leaders and plan sponsors face several questions and unknowns regarding how they will address GLP-1s in their strategic benefit plan offerings. This may be the most important benefit plan change to consider this year: How to prioritize employee health while managing pharmacy spend, defining successful outcomes and having guardrails around who is eligible for coverage.
Obesity is a serious health issue requiring real, tangible support. It's time to move beyond the traditional boundaries of healthcare benefits and create a supportive and inclusive environment for all employees. Join our interactive discussion to learn more about:
Thank you for your interest in the webinar! Check your inbox for an email with instructions on viewing this on-demand presentation.Download Now
Enter the 6 digit code sent to your mobile number
Click on Resend the verification code again